Is Quest Diagnostics Stock Outperforming the S&P 500? Although Quest Diagnostics has outperformed the S&P 500 Index over the past year, analysts are cautiously optimistic about the stock’s prospects. Barchart · Mar 27, 2025
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? Despite Quest Diagnostics' outperformance relative to its industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Dec 23, 2024
What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock? Despite Quest Diagnostics’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects. Barchart · Nov 26, 2024
Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know With Quest Diagnostics gearing up to release its third-quarter earnings later this month, analysts expect a low single-digit earnings growth. Barchart · Oct 4, 2024
Quest Diagnostics Stock: Is Wall Street Bullish or Bearish? As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects. Barchart · Aug 27, 2024
Quest Diagnostics’ Q2 2024 Earnings: What to Expect As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects. Barchart · Jul 4, 2024
Should You Be Able To Take an Alzheimer's Test at Home? Plus, an AI-generated version of the same article Reason · May 23, 2024
You can help Google with its latest Fitbit study on metabolic health Fitbit and Pixel Watch owners can participate in a metabolic health study, which involves providing digital health data and a blood sample. Android Central · Jan 18, 2024
Workers test positive for weed at highest rate since 1997 Amphetamine use is on the rise as well. Fortune · May 18, 2023
Legal pot raises questions about the future of workplace drug policies in Missouri ST. LOUIS — While marijuana legalization proponents celebrated victory in their fight for recreational cannabis, Missouri business owners were phoning their lawyers. St. Louis Post-Dispatch · Nov 15, 2022
Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%. Benzinga · Aug 10, 2022
US boosts monkeypox testing, 142 cases confirmed The Biden administration has started shipping testing kits for monkeypox to commercial laboratories, in a bid to speed diagnostic tests for suspected infections for the virus that has already infected at least 142 people in the U.S. The Centers for Disease Control and Prevention is sending tests to commercial labs,… The Independent UK · Jun 22, 2022
5 Value Stocks To Watch In The Healthcare Sector The Meaning Behind Value Stocks Benzinga · Jun 13, 2022
5 Value Stocks To Watch In The Healthcare Sector What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. Benzinga · May 2, 2022
Benzinga · Apr 21, 2022 Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance Quest Diagnostics Inc (NYSE:DGX) posted a better-than-expected Q1 FY22 adjusted EPS of $3.22, down 14.4% Y/Y, beating the consensus of $2.97. Sales came in at $2.61 billion, a decline of 4% Y/Y, slightly lower than the Wall Street estimate of $2.63 billion. COVID-19 testing revenues fell 27.6% to $599 million, while Base…
Benzinga · Apr 21, 2022 Quest Diagnostics: Q1 Earnings Insights Quest Diagnostics (NYSE:DGX) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
Benzinga · Apr 20, 2022 Quest Diagnostics's Earnings: A Preview Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.97.
Benzinga · Apr 4, 2022 Analyst Ratings For Quest Diagnostics Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter:
Axios · Mar 30, 2022 Positive drug tests for U.S. workers hit highest level since 2001 Overall positivity rate last year were up around 31% from all-time lows between 2010 and 2012.
Salon · Mar 28, 2022 Uninsured will now pay for COVID tests Government funding cuts to key pandemic programs forced by GOP opposition arrive as progressives in Congress renew their push for Medicare for All.
Benzinga · Mar 24, 2022 Quest Diagnostics Secures CDC Contract To Support COVID-19 Research The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis. Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…
Benzinga · Mar 3, 2022 This Foreboding Sign Looms Over Quest Diagnostics's Chart If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Tribune News Service · Mar 2, 2022 Los trabajadores que usan cannabis legalmente aún pueden perder sus trabajos Treinta y siete estados ahora le permiten a los adultos consumir marihuana con fines médicos, recreativos o ambos. Pero, en la mayoría de esos estados, las personas pueden ser despedidas o se les puede negar un trabajo si consumen cannabis en su tiempo libre.